Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

The placenta: A site of end-organ damage after Fontan operation. A case series.

Phillips AL, Cetta F, Kerr SE, Cheek EH, Rose CH, Bonnichsen CR, Phillips SD.

Int J Cardiol. 2019 Feb 5. pii: S0167-5273(18)35812-1. doi: 10.1016/j.ijcard.2019.02.002. [Epub ahead of print]

PMID:
30765280
2.

Patient recommendations for PrEP information dissemination at family planning clinics in Atlanta, Georgia.

Sales JM, Phillips AL, Tamler I, Munoz T, Cwiak C, Sheth AN.

Contraception. 2019 Jan 31. pii: S0010-7824(19)30012-5. doi: 10.1016/j.contraception.2018.12.008. [Epub ahead of print]

PMID:
30711352
3.

A real-world comparison of relapse rates, healthcare costs and resource use among patients with multiple sclerosis newly initiating subcutaneous interferon beta-1a versus oral disease-modifying drugs.

Bowen JD, Kozma CM, Grosso MM, Phillips AL.

Mult Scler J Exp Transl Clin. 2018 Dec 17;4(4):2055217318819031. doi: 10.1177/2055217318819031. eCollection 2018 Oct-Dec.

4.

Early experience of implementing a national HIV pre-exposure prophylaxis service in Wales, United Kingdom 2017.

Fina L, Phillips AL, Jones AT, Couzens ZM, Drayton R, Thomas DR, Shankar AG.

Sex Health. 2018 Dec 3. doi: 10.1071/SH18091. [Epub ahead of print]

PMID:
30501846
5.

Pregnancy rates and outcomes in women with and without MS in the United States.

Houtchens MK, Edwards NC, Schneider G, Stern K, Phillips AL.

Neurology. 2018 Oct 23;91(17):e1559-e1569. doi: 10.1212/WNL.0000000000006384. Epub 2018 Sep 28.

6.

Relapses and disease-modifying drug treatment in pregnancy and live birth in US women with MS.

Houtchens MK, Edwards NC, Phillips AL.

Neurology. 2018 Oct 23;91(17):e1570-e1578. doi: 10.1212/WNL.0000000000006382. Epub 2018 Sep 28.

7.

Evaluating the Use of Silicone Wristbands To Measure Personal Exposure to Brominated Flame Retardants.

Hammel SC, Phillips AL, Hoffman K, Stapleton HM.

Environ Sci Technol. 2018 Oct 2. doi: 10.1021/acs.est.8b03755. [Epub ahead of print]

PMID:
30216050
8.

rTMS effects in patients with co-morbid somatic pain and depressive mood disorders.

Phillips AL, Burr RL, Dunner DL.

J Affect Disord. 2018 Dec 1;241:411-416. doi: 10.1016/j.jad.2018.08.065. Epub 2018 Aug 18.

PMID:
30145511
9.

Ranking Coal Ash Materials for Their Potential to Leach Arsenic and Selenium: Relative Importance of Ash Chemistry and Site Biogeochemistry.

Schwartz GE, Hower JC, Phillips AL, Rivera N, Vengosh A, Hsu-Kim H.

Environ Eng Sci. 2018 Jul 1;35(7):728-738. doi: 10.1089/ees.2017.0347.

10.

Biomarkers of exposure to SVOCs in children and their demographic associations: The TESIE Study.

Hoffman K, Hammel SC, Phillips AL, Lorenzo AM, Chen A, Calafat AM, Ye X, Webster TF, Stapleton HM.

Environ Int. 2018 Oct;119:26-36. doi: 10.1016/j.envint.2018.06.007. Epub 2018 Jun 18.

PMID:
29929048
11.

Children's residential exposure to organophosphate ester flame retardants and plasticizers: Investigating exposure pathways in the TESIE study.

Phillips AL, Hammel SC, Hoffman K, Lorenzo AM, Chen A, Webster TF, Stapleton HM.

Environ Int. 2018 Jul;116:176-185. doi: 10.1016/j.envint.2018.04.013. Epub 2018 Apr 21.

PMID:
29689464
12.

Letter to the Editor Regarding "HIV Testing at Visits to Physicians' Offices in the U.S., 2009-2012".

Phillips AL, Patel S, Kumar D, Arya M.

Am J Prev Med. 2018 May;54(5):724-725. doi: 10.1016/j.amepre.2018.01.023. No abstract available.

PMID:
29680122
13.

Factors associated with early initiation of disease-modifying drug treatment in newly-diagnosed patients with multiple sclerosis.

Edwards NC, Munsell M, Menzin J, Phillips AL.

Curr Med Res Opin. 2018 Aug;34(8):1389-1395. doi: 10.1080/03007995.2018.1447452. Epub 2018 Mar 12.

PMID:
29493313
14.

Comorbidity in US patients with multiple sclerosis.

Edwards NC, Munsell M, Menzin J, Phillips AL.

Patient Relat Outcome Meas. 2018 Feb 13;9:97-102. doi: 10.2147/PROM.S148387. eCollection 2018.

15.

Wheat receptor-kinase-like protein Stb6 controls gene-for-gene resistance to fungal pathogen Zymoseptoria tritici.

Saintenac C, Lee WS, Cambon F, Rudd JJ, King RC, Marande W, Powers SJ, Bergès H, Phillips AL, Uauy C, Hammond-Kosack KE, Langin T, Kanyuka K.

Nat Genet. 2018 Mar;50(3):368-374. doi: 10.1038/s41588-018-0051-x. Epub 2018 Feb 12.

PMID:
29434355
16.

EDC IMPACT: Molecular effects of developmental FM 550 exposure in Wistar rat placenta and fetal forebrain.

Rock KD, Horman B, Phillips AL, McRitchie SL, Watson S, Deese-Spruill J, Jima D, Sumner S, Stapleton HM, Patisaul HB.

Endocr Connect. 2018 Feb;7(2):305-324. doi: 10.1530/EC-17-0373. Epub 2018 Jan 19.

17.

The early inflorescence of Arabidopsis thaliana demonstrates positional effects in floral organ growth and meristem patterning.

Plackett ARG, Powers SJ, Phillips AL, Wilson ZA, Hedden P, Thomas SG.

Plant Reprod. 2018 Jun;31(2):171-191. doi: 10.1007/s00497-017-0320-3. Epub 2017 Dec 20.

18.

Lambl's excrescences in children: Improved detection via transthoracic echocardiography.

Phillips AL, Qureshi MY, Eidem BW, Cetta F.

Congenit Heart Dis. 2018 Mar;13(2):251-253. doi: 10.1111/chd.12560. Epub 2017 Nov 27.

PMID:
29181873
19.

Sexual and Reproductive Health Services and Related Health Information on Pregnancy Resource Center Websites: A Statewide Content Analysis.

Swartzendruber A, Newton-Levinson A, Feuchs AE, Phillips AL, Hickey J, Steiner RJ.

Womens Health Issues. 2018 Jan - Feb;28(1):14-20. doi: 10.1016/j.whi.2017.10.007. Epub 2017 Nov 20.

PMID:
29158038
20.

Characterization of Individual Isopropylated and tert-Butylated Triarylphosphate (ITP and TBPP) Isomers in Several Commercial Flame Retardant Mixtures and House Dust Standard Reference Material SRM 2585.

Phillips AL, Hammel SC, Konstantinov A, Stapleton HM.

Environ Sci Technol. 2017 Nov 21;51(22):13443-13449. doi: 10.1021/acs.est.7b04179. Epub 2017 Nov 13.

21.

Sex Specific Placental Accumulation and Behavioral Effects of Developmental Firemaster 550 Exposure in Wistar Rats.

Baldwin KR, Phillips AL, Horman B, Arambula SE, Rebuli ME, Stapleton HM, Patisaul HB.

Sci Rep. 2017 Aug 2;7(1):7118. doi: 10.1038/s41598-017-07216-6.

22.

Associations between flame retardant applications in furniture foam, house dust levels, and residents' serum levels.

Hammel SC, Hoffman K, Lorenzo AM, Chen A, Phillips AL, Butt CM, Sosa JA, Webster TF, Stapleton HM.

Environ Int. 2017 Oct;107:181-189. doi: 10.1016/j.envint.2017.07.015. Epub 2017 Jul 24.

23.
24.

An improved assembly and annotation of the allohexaploid wheat genome identifies complete families of agronomic genes and provides genomic evidence for chromosomal translocations.

Clavijo BJ, Venturini L, Schudoma C, Accinelli GG, Kaithakottil G, Wright J, Borrill P, Kettleborough G, Heavens D, Chapman H, Lipscombe J, Barker T, Lu FH, McKenzie N, Raats D, Ramirez-Gonzalez RH, Coince A, Peel N, Percival-Alwyn L, Duncan O, Trösch J, Yu G, Bolser DM, Namaati G, Kerhornou A, Spannagl M, Gundlach H, Haberer G, Davey RP, Fosker C, Palma FD, Phillips AL, Millar AH, Kersey PJ, Uauy C, Krasileva KV, Swarbreck D, Bevan MW, Clark MD.

Genome Res. 2017 May;27(5):885-896. doi: 10.1101/gr.217117.116.

25.

The association of timing of disease-modifying drug initiation and relapse in patients with multiple sclerosis using electronic health records.

Corvino FA, Oliveri D, Phillips AL.

Curr Med Res Opin. 2017 Jun;33(6):1127-1132. doi: 10.1080/03007995.2017.1308918. Epub 2017 Apr 11.

PMID:
28318337
26.

An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug.

Munsell M, Frean M, Menzin J, Phillips AL.

Patient Prefer Adherence. 2016 Dec 30;11:55-62. doi: 10.2147/PPA.S118107. eCollection 2017.

27.

Uncovering hidden variation in polyploid wheat.

Krasileva KV, Vasquez-Gross HA, Howell T, Bailey P, Paraiso F, Clissold L, Simmonds J, Ramirez-Gonzalez RH, Wang X, Borrill P, Fosker C, Ayling S, Phillips AL, Uauy C, Dubcovsky J.

Proc Natl Acad Sci U S A. 2017 Feb 7;114(6):E913-E921. doi: 10.1073/pnas.1619268114. Epub 2017 Jan 17.

28.

Individual Differences in Diurnal Preference and Time-of-Exercise Interact to Predict Exercise Frequency.

Hisler GC, Phillips AL, Krizan Z.

Ann Behav Med. 2017 Jun;51(3):391-401. doi: 10.1007/s12160-016-9862-0.

PMID:
27909945
29.

Trauma-Informed HIV Prevention and Treatment.

Sales JM, Swartzendruber A, Phillips AL.

Curr HIV/AIDS Rep. 2016 Dec;13(6):374-382. Review.

30.

Dioxygenase-encoding AtDAO1 gene controls IAA oxidation and homeostasis in Arabidopsis.

Porco S, Pěnčík A, Rashed A, Voß U, Casanova-Sáez R, Bishopp A, Golebiowska A, Bhosale R, Swarup R, Swarup K, Peňáková P, Novák O, Staswick P, Hedden P, Phillips AL, Vissenberg K, Bennett MJ, Ljung K.

Proc Natl Acad Sci U S A. 2016 Sep 27;113(39):11016-21. doi: 10.1073/pnas.1604375113. Epub 2016 Sep 20.

31.

Characterization of a Wheat Breeders' Array suitable for high-throughput SNP genotyping of global accessions of hexaploid bread wheat (Triticum aestivum).

Allen AM, Winfield MO, Burridge AJ, Downie RC, Benbow HR, Barker GL, Wilkinson PA, Coghill J, Waterfall C, Davassi A, Scopes G, Pirani A, Webster T, Brew F, Bloor C, Griffiths S, Bentley AR, Alda M, Jack P, Phillips AL, Edwards KJ.

Plant Biotechnol J. 2017 Mar;15(3):390-401. doi: 10.1111/pbi.12635. Epub 2016 Nov 23.

32.

mlo-based powdery mildew resistance in hexaploid bread wheat generated by a non-transgenic TILLING approach.

Acevedo-Garcia J, Spencer D, Thieron H, Reinstädler A, Hammond-Kosack K, Phillips AL, Panstruga R.

Plant Biotechnol J. 2017 Mar;15(3):367-378. doi: 10.1111/pbi.12631. Epub 2016 Sep 25.

33.

Editor's Highlight: Transplacental and Lactational Transfer of Firemaster® 550 Components in Dosed Wistar Rats.

Phillips AL, Chen A, Rock KD, Horman B, Patisaul HB, Stapleton HM.

Toxicol Sci. 2016 Oct;153(2):246-57. doi: 10.1093/toxsci/kfw122. Epub 2016 Jun 30.

34.

Raising Awareness: The Overlapping Epidemics of Low Health Literacy and HIV.

Phillips AL, Arya M.

J Assoc Nurses AIDS Care. 2016 Jul-Aug;27(4):372-5. doi: 10.1016/j.jana.2016.02.008. Epub 2016 Apr 7. No abstract available.

35.

Physician Preferences for Physician-Targeted HIV Testing Campaigns.

Arya M, Phillips AL, Street RL Jr, Giordano TP.

J Int Assoc Provid AIDS Care. 2016 Nov;15(6):470-476. Epub 2016 Mar 21.

36.

Deep roots and soil structure.

Gao W, Hodgkinson L, Jin K, Watts CW, Ashton RW, Shen J, Ren T, Dodd IC, Binley A, Phillips AL, Hedden P, Hawkesford MJ, Whalley WR.

Plant Cell Environ. 2016 Aug;39(8):1662-8. doi: 10.1111/pce.12684. Epub 2016 Feb 5. No abstract available.

37.

Real-World Assessment of Relapse, Medical Costs and Persistency of Multiple Sclerosis Patients Treated With Subcutaneous Interferon β-1a.

Phillips AL, Locklear JC, Kozma C.

Value Health. 2015 Nov;18(7):A755. doi: 10.1016/j.jval.2015.09.2928. Epub 2015 Oct 20. No abstract available.

38.

Cost Offset Analysis of Interferon Beta Disease Modifying Therapies In Relapsing-Remitting Multiple Sclerosis.

Beckerman R, Locklear JC, Smith NJ, Phillips AL.

Value Health. 2015 Nov;18(7):A752. doi: 10.1016/j.jval.2015.09.2912. Epub 2015 Oct 20. No abstract available.

39.

Best Practices for Network Meta-Analysis Methodology: Comparative Effectiveness of Interferon-Beta Therapies In Relapsing-Remitting Multiple Sclerosis.

Beckerman R, Locklear JC, Jiang Y, Solon C, Smith NJ, Phillips AL.

Value Health. 2015 Nov;18(7):A696. doi: 10.1016/j.jval.2015.09.2594. Epub 2015 Oct 20. No abstract available.

40.

Overlap of HIV and low health literacy in the southern USA.

Baumann KE, Phillips AL, Arya M.

Lancet HIV. 2015 Jul;2(7):e269-70. doi: 10.1016/S2352-3018(15)00121-6. Epub 2015 Jun 24. No abstract available.

41.

Mutation Scanning in Wheat by Exon Capture and Next-Generation Sequencing.

King R, Bird N, Ramirez-Gonzalez R, Coghill JA, Patil A, Hassani-Pak K, Uauy C, Phillips AL.

PLoS One. 2015 Sep 3;10(9):e0137549. doi: 10.1371/journal.pone.0137549. eCollection 2015.

42.

The effect of impedance to root growth on plant architecture in wheat.

Jin K, Shen J, Ashton RW, White RP, Dodd IC, Phillips AL, Parry MA, Whalley WR.

Plant Soil. 2015;392(1-2):323-332. Epub 2015 Apr 11.

43.

Heterologous expression and transcript analysis of gibberellin biosynthetic genes of grasses reveals novel functionality in the GA3ox family.

Pearce S, Huttly AK, Prosser IM, Li YD, Vaughan SP, Gallova B, Patil A, Coghill JA, Dubcovsky J, Hedden P, Phillips AL.

BMC Plant Biol. 2015 Jun 5;15:130. doi: 10.1186/s12870-015-0520-7.

44.

The effect of age and sex on cost of inpatient facility encounters among patients with multiple sclerosis.

Kozma CM, Meletiche DM, Phillips AL.

J Med Econ. 2015;18(9):704-10. doi: 10.3111/13696998.2015.1044995. Epub 2015 Jun 12.

PMID:
25913916
45.

Evaluation of Patient and Financial Outcomes Associated With Advanced Infertility Treatment Options.

Locklear J, Bozkaya D, Migliaccio K, Bramley T, Phillips AL, Mahony M.

Value Health. 2014 Nov;17(7):A519-20. doi: 10.1016/j.jval.2014.08.1619. Epub 2014 Oct 26. No abstract available.

46.

Using a Panel Survey to Identify Predictors of Disease-Modifying Drug Adherence in Patients with Multiple Sclerosis.

Phillips AL, Kozma CM, Locklear JC.

Value Health. 2014 Nov;17(7):A400. doi: 10.1016/j.jval.2014.08.910. Epub 2014 Oct 26. No abstract available.

47.

Cost-Effectiveness of Subcutaneous Interferon Beta-1A in a Sub-Population of Multiple Sclerosis Patients (Kurtzke Expanded Disability Status Scale [EDSS]: >3.5-5.0).

Phillips AL, Edwards NC, Locklear JC.

Value Health. 2014 Nov;17(7):A398. doi: 10.1016/j.jval.2014.08.899. Epub 2014 Oct 26. No abstract available.

48.

An Economic Evaluation of Subcutaneous and Intramuscular Interferon Beta-1a in Multiple Sclerosis Using a Direct Head-To-Head Study.

Phillips AL, Edwards NC, Locklear JC.

Value Health. 2014 Nov;17(7):A397. doi: 10.1016/j.jval.2014.08.894. Epub 2014 Oct 26. No abstract available.

49.

Cost-Effectiveness Evaluation of Data from the Evidence (Evidence of Interferon Dose-Response: European North American Comparative Efficacy) Study.

Phillips AL, Edwards NC, Locklear JC.

Value Health. 2014 Nov;17(7):A397. doi: 10.1016/j.jval.2014.08.895. Epub 2014 Oct 26. No abstract available.

50.

A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database.

Phillips AL, Munsell MJ, Menzin J, Dangond F, Locklear JC.

Value Health. 2014 Nov;17(7):A392. doi: 10.1016/j.jval.2014.08.867. Epub 2014 Oct 26. No abstract available.

Supplemental Content

Loading ...
Support Center